Dementia with Lewy bodies. Review of diagnosis and pharmacologic management

Canadian Family Physician

Volumn 49, Issue OCT., 2003, Pages 1304-1311

  Frank, Christopher ^a  

^a Providence Continuing Care Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBIDOPA PLUS LEVODOPA; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE;

CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DEMENTIA; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HALLUCINATION; HUMAN; HYPOTENSION; LEWY BODY; MEDICAL CARE; MEDICAL LITERATURE; MEDLINE; NAUSEA; NAUSEA AND VOMITING; NIGHTMARE; PARKINSONISM; PRACTICE GUIDELINE; PSYCHOSIS; REVIEW; RISK MANAGEMENT; SYMPTOMATOLOGY; VISUAL HALLUCINATION;

ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; LEWY BODY DISEASE;

EID: 0142155226     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Ebly EM, Parha IM, Hogan DB, Fung T. Prevalence and types of dementia in the very old: results from the Canadian Study on Health and Aging. Neurology 1994;44:1593-600.
2. McKeith IG, Galasko DR, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
3. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902-5.
4. Stevens T, Livingston G, Kitchen G, Manela M, Walker Z, Katona CL, Islington study of dementia subtypes in the community. Br J Psychiatry 2002;180:270-6.
5. Walker Z, Allen RL, Shergill S, Mullan E, Katona CL. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 2000;15:267-73.
6. Lopez OL, Wisniewski S, Hamilton RL, Becker JT, Kaufer DI, DeKosky ST. Predictors of progression in patients with AD and Lewy bodies. Neurology 2000;54:1774-9.
7. Del Ser T, McKeith IG. Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Dementia with Lewy bodies: findings from an international multicentre study. Int J Geriatr Psychiatry 2000;15:1034-45.
8. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16(4):622-30.
9. Ballard C, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1999;10:104-8.
10. Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000;57(4):489-93.
11. Doubleday EK, Snowden JS, Varma AR, Neary D. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:602-7.
12. Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The Mini-Mental State Exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2002;17:503-9.
13. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg 1998;64:588-94.
14. Ballard CG, O'Brien JT, Swann AG, Thompson P, Neill D, McKeith IG. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. J Clin Psychiatry 2001;62(1):46-9.
15. Rockwell E, Choure J, Galasko DR, Olichney J, Jeste DV. Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry 2000;15:819-23.
16. Walker MP, Ballard C. The clinician assessment of fluctuation and the one day fluctuation assessment scale. Br J Psychiatry 2000;177:252-6.
17. Walker MP, Ayre G, Cummings JL, Wesnes K, McKeith IG, O'Brien J, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2000;54:1616-25.
18. Aarsland D, Ballard C, McKeith IG, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13(3):374-9.
19. Imamura T, Hirono N, Hashimoto M, Kazui H, Tanimukai S, Hanihara T, et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol 2002;7(1):77-9.
20. Ballard CG, Shaw F, Lowerey K, McKeith IG, Kenny R. The prevalence, assessment and association of falls in dementia with Lewy body disease and Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:97-103.
21. Serby M, Samuels SC. Diagnostic criteria for dementia with Lewy bodies reconsidered. Am J Geriatr Psychiatry 2001;9(3):212-6.
22. Holmes C, Cairns M, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999;174:45-50.
23. Luis CA, Barker WW, Gajara K, Harwood D, Petersen R, Kashuba A, et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy verified sample. Int J Geriatr Psychiatry 1999;14:526-33.
24. Mega MS, Masterman D, Benson F, Vinters HV, Tomiyasu U, Craig AH, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. Neurology 1996;47:1403-7.
25. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050-8.
26. Lopez OL, Hamilton RL, Becker JT, Wisniewski S, Kaufer DI, DeKosky ST. Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000;54:1780-7.
27. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien J, Medical temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999;52:1153-8.
28. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:911-6.
29. Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien J. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord 2001;12:198-205.
30. Barber R, McKeith IG, Ballard C, O'Brien J. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies. Alzheimer's disease, and vascular dementia. J Neurol Neurosurg Psychiatry 2002;72:406-7.
31. O'Brien J, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001;56:1386-8.
32. O'Brien JT, Metcalfe s, Swann A, Hobson J, Jobst K, Ballard C, et al. Medial temporal lobe within on CT scanning in Alzheimer's disease: comparison with vascular dementia, depression and dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000;11:114-8.
33. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000;54:1304-9.
34. Briel RD, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, et al. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;66:401-3.
35. Steinling M, Devebvre L, Duhamel A, Lecouffe P, Lavenue I, Pasquier F, et al. Is there a typical pattern of brain SPECT imaging in Alzheimer's disease? Dement Geriatr Cogn Disord 2001;12:371-8.
36. Cordery RJ, Tyrrell PJ, Lantos PL, Rossor MN. Dementia with Lewy bodies studied with positron emission tomography. Arch Neurol 2001;58(3):505-8.
37. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-9.
38. Gomez-Tortosa E, Ingraham AO, Irizarry MC, Hyman BT. Dementia with Lewy bodies. J Am Geriatr Soc 1998;46:1449-58.
39. Kaufer DI, Catt KE, Lopez OL, DeKosky ST. Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 1998;51:1512.
40. Wesnes K, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, et al. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomized placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 2002;13:183-92.
41. McKeith IG, Grace J, Walker Z, Byrne EJ, Wilkinson D, Stevens T, et al. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 2000;15:387-92.
42. Maclean LE, Collins CC, Byrne EJ. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.Int Psychogeriatr 2001;13(3):277-88.
43. Grace J, Daniel S, Stevens T, Shankar KK, Walker Z, Byrne EJ, et al. Long-term use of rivastigmine in patients wih dementia with Lewy bodies: an open-label trial. Int Psychogeriatr 2001;13(2):199-205.
44. Samuel W, Caligiuri M, Galasko DR, Lacro J, Marini M, McClure FS, et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 2000;15:794-802.
45. Querfurth HW, Allam GJ, Geffroy MA, Schiff HB, Kaplan RF. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial. Dement Geriatr Cogn Disord 2000;11:314-21.
46. McKeith IG, Del Ser T, Spano PF, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356(9247):2031-6.
47. Shea C, MacKnight C, Rockwood K. Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr 1998;10(3):229-38.
48. Cummings JL. Cholinesterase inhibitors: expanding applications. Lancet 2000;356(9247):2024-5.
49. Byrne EJ, Lennox G, Lowe J. Diffuse Lewy body disease, clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;47:709-17.
50. Geroldi C, Frisoni GB, Bianchetti A, Trabucci M. Drug treatment in Lewy body dementia. Dement Geriatr Cogn Disord 1997;8:188-97.
51. Sechi G, Agnetti V, Masuri R, Deiana GA, Pugliatti M, Paulus KS, et al. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 2000;24(6):1043-51.
52. Kato K, Wada T, Kawakatsu S, Otani K. Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA. Prog Neuropsychopharmacol Biol Psychiatry 2002;26(1):201-3.
53. Fernandez HH, Trieschmann ME, Burke MA, Friedman JH. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. J Clin Psychiatry 2002;63(6):513-5.
54. Walker Z, Grace J, Oveshot R, Satarasinghe S, Swann A, Katona CL, et al. Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 1999;14:459-66.
55. Cummings JL, Street J, Masterman D, Clark WS. Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002;13:67-73.